← Open Payments lookup

MARIE RENOIT: Open Payments

NPI 1932209814 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,016 in 75 payments from 15 companies in 2025. Trend: 2023 $1,000 · 2024 $1,457 · 2025 $2,016

Food & beverage: $2,016
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP16$386
SCPHARMACEUTICALS INC.6$262
Actelion Pharmaceuticals US, Inc.7$233
Merck Sharp & Dohme LLC8$194
Alnylam Pharmaceuticals Inc.4$191
PFIZER INC.7$140
Bayer Healthcare Pharmaceuticals Inc.6$133
Novo Nordisk Inc5$100
E.R. Squibb & Sons, L.L.C.4$94
United Therapeutics Corporation3$78

Products named: FUROSCIX, UPTRAVI, WAINUA, AMVUTTRA, WINREVAIR, VYNDAQEL, FARXIGA, Kerendia.

Industry payments across FL — which companies pay providers there.